Company Analysis America Great Health
1. Summary
Advantages
- Price (0.0001 $) is less than fair price (0.0071 $)
- The company's current efficiency (ROE=17.11%) is higher than the sector average (ROE=13.19%)
Disadvantages
- Dividends (0%) are below the sector average (1.76%).
- The stock's return over the last year (-99.23%) is lower than the sector average (-34.04%).
- Current debt level 625.24% has increased over 5 years from 0%.
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| America Great Health | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | 4.6% | -0.1% |
| 90 days | -80% | -37.6% | 6.5% |
| 1 year | -99.2% | -34% | 25% |
AAGH vs Sector: America Great Health has significantly underperformed the "Healthcare" sector by -65.19% over the past year.
AAGH vs Market: America Great Health has significantly underperformed the market by -124.2% over the past year.
Slightly volatile price: AAGH is more volatile than the rest of the market on "OTC" over the last 3 months, with typical deviations of about +/- 5-15% per week.
Long period: AAGH with weekly volatility of -1.91% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (0.0001 $) is lower than the fair price (0.0071 $).
Price significantly below the fair price: The current price (0.0001 $) is 7000% lower than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (0) is lower than that of the sector as a whole (31.48).
P/E vs Market: The company's P/E (0) is lower than that of the market as a whole (46.91).
4.3. P/BV
P/BV vs Sector: The company's P/BV (-13.98) is lower than that of the sector as a whole (3.36).
P/BV vs Market: The company's P/BV (-13.98) is lower than that of the market as a whole (-8.98).
4.4. P/S
P/S vs Sector: The company's P/S indicator (309.73) is higher than that of the sector as a whole (3.24).
P/S vs Market: The company's P/S indicator (309.73) is higher than that of the market as a whole (4.88).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-145.53) is lower than that of the sector as a whole (9.95).
EV/Ebitda vs Market: The company's EV/Ebitda (-145.53) is lower than that of the market as a whole (25.28).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -20% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-20%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-52.93%).
5.4. ROE
ROE vs Sector: The company's ROE (17.11%) is higher than that of the sector as a whole (13.19%).
ROE vs Market: The company's ROE (17.11%) is higher than that of the market as a whole (-8.22%).
5.5. ROA
ROA vs Sector: The company's ROA (-254.55%) is lower than that of the sector as a whole (6.14%).
ROA vs Market: The company's ROA (-254.55%) is lower than that of the market as a whole (4.85%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (15.56%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (11.03%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.76%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
